MIMOSA Diagnostics Inc

MIMOSA Diagnostics Inc has 1 AI-enabled medical device on the FDA list. The first decision was on November 1, 2019 and the most recent on November 1, 2019 (MIMOSA Imager). Its most common review panel is Cardiovascular (1 device).